Co-Diagnostics Market Cap

Co-Diagnostics has a market cap or net worth of 14.8 million as of November 4, 2025. Its market cap has decreased by -51.73% in one year.

Market Cap

14.80M

Enterprise Value

5.93M

Revenue

732.57K

Ranking

n/a

PE Ratio

n/a

Stock Price

0.49

Market Cap Chart

Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 14.80M, a decrease of -72.47%. That is a compound annual growth rate of -14.37%.

Market Cap History

Date	Market Cap	% Change
Nov 3, 2025	14.80M	-22.63%
Dec 31, 2024	19.13M	-40.10%
Dec 29, 2023	31.93M	-50.62%
Dec 30, 2022	64.66M	-66.38%
Dec 31, 2021	192.31M	-0.13%
Dec 31, 2020	192.56M	1,542.95%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jul 12, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	193.37B
HSBC Holdings	182.60B
Shell	164.70B
Unilever	114.25B
Rolls-Royce Holdings	98.20B
Rio Tinto Group	93.32B
British American Tobacco p.l.c.	84.99B
GSK plc	71.57B

Market Cap Rankings